PharmaDEXI
ActiveSummary
The computed 12-month bankruptcy probability of PharmaDEXI is 13.4% (high). For PharmaDEXI, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show negative equity (-€40,156) and a net result of -€14,540. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Bankruptcy probability: High
Filing: At least two filing cycles are missing
Axes, FY 2023 · tick = 2022
Profitability0=
Solvency0=
Growth58
Track record94
Bankruptcy probability, 12 months
13.4%
High
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2023Solvency, return and age of the figures
Solvency
-136.3%
Return on assets
-49.4%
Age of the figures
33 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 2 filingsPosition against the passed deadline
31-12-2024 close31-07-2025 deadline28-09-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 30-08-2024, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
30 d late
2022
14 d late
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 2 accounts on average 22 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2023, micro schema
Equity
-€40,156▼ 56.8%
2022 · -€25,616
Total assets
€29,457▼ 6.4%
2022 · €31,477
Net result
-€14,540▲ 52.5%
2022 · -€30,616
Working capital
-€57,492▼ 25.6%
2022 · -€45,770
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20222023
Operating result-€30,539--€14,459▲ 52.7%
Net result-€30,616--€14,540▲ 52.5%
Equity-€25,616--€40,156▼ 56.8%
Total assets€31,477-€29,457▼ 6.4%
Debt€57,093-€69,612▲ 21.9%
Working capital-€45,770--€57,492▼ 25.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €14,459 in 2023 against €30,539 in 2022; the loss shrinks.
Balance-sheet composition
2023 in colour, 2022 as the grey bar beneath
Assets €29,457
Fixed assets
€17,337 ▼ 14.0%
Current assets
€12,120 ▲ 7.0%
Key figures and ratios
EBITDA
-€11,642▲
2022 · -€15,980
Cash flow
-€11,723▲
2022 · -€16,057
Solvency
-136.3%▼
2022 · -81.4%
Current ratio
0.17▼
2022 · 0.20
Debt to equity
-1.73▲
2022 · -2.23
ROA
-49.4%▲
2022 · -97.3%
Interest coverage
-143.81▲
2022 · -207.61
Debt ≤ 1 year
€69,612▲
2022 · €57,093
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €14,559 | €2,817 | ▼ 80.6% |
| Other operating charges640/8 | €62 | €2,390 | ▲ 3,751% |
| Gross operating margin9900 | -€15,918 | -€9,252 | ▲ 41.9% |
| Operating profit (loss)9901 | -€30,539 | -€14,459 | ▲ 52.7% |
| Financial charges65/66B | €77 | €81 | ▲ 5.2% |
| Recurring financial charges65 | €77 | €81 | ▲ 5.2% |
| Profit (loss) for the period before taxes9903 | -€30,616 | -€14,540 | ▲ 52.5% |
| Profit (loss) for the period9904 | -€30,616 | -€14,540 | ▲ 52.5% |
| Profit (loss) for the period to be appropriated9905 | -€30,616 | -€14,540 | ▲ 52.5% |
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €31,477 | €29,457 | ▼ 6.4% |
| Fixed assets21/28 | €20,154 | €17,337 | ▼ 14.0% |
| Intangible fixed assets21 | €19,254 | €16,437 | ▼ 14.6% |
| Financial fixed assets28 | €900 | €900 | = |
| Current assets29/58 | €11,323 | €12,120 | ▲ 7.0% |
| Amounts receivable within one year40/41 | €11,323 | €10,472 | ▼ 7.5% |
| Trade receivables40 | €9,155 | €10,159 | ▲ 11.0% |
| Other amounts receivable41 | €2,168 | €313 | ▼ 85.6% |
| Cash at bank and in hand54/58 | - | €1,648 | - |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €31,477 | €29,457 | ▼ 6.4% |
| Equity10/15 | -€25,616 | -€40,156 | ▼ 56.8% |
| Contributions10/11 | €5,000 | €5,000 | = |
| Profit (loss) carried forward14 | -€30,616 | -€45,156 | ▼ 47.5% |
| Amounts payable17/49 | €57,093 | €69,612 | ▲ 21.9% |
| Amounts payable within one year42/48 | €57,093 | €69,612 | ▲ 21.9% |
| Financial debts43 | €4,510 | - | - |
| Credit institutions430/8 | €4,510 | - | - |
| Trade debts44 | €13,438 | €12,422 | ▼ 7.6% |
| Suppliers440/4 | €13,438 | €12,422 | ▼ 7.6% |
| Advances received on contracts in progress46 | €830 | - | - |
| Other amounts payable47/48 | €38,315 | €57,190 | ▲ 49.3% |
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | -€30,616 | -€14,540 | ▲ 52.5% |
| + Depreciation and write-downs630 | €14,559 | €2,817 | ▼ 80.6% |
| Operating cash flow (approximation) | -€16,057 | -€11,723 | ▲ 27.0% |
| Investment in fixed assets (approximation) | - | €0 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
14-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 14 days late
NBB filing
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2021
Ground area
1,244 m²
Building footprint
389 m²
Volume, LiDAR
3,638 m³
Parcel 21447B0298/00W013, Brussels · tallest building 19.6 m, ±4 floors. Linked by address, not a title deed.
13
companies at this address
See who is registered here
1 establishment unit
PharmaDEXI
since 20212.320.278.404
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21447B0298/00W013 | Brussels | 1,244 m² | 1 · 389 m² | 19.6 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Identification & contact
Identification
Legal formPrivate limited company
Founded15-07-2021
Fiscal year end31-12
E-invoicing
Not found in the Peppol register
No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.